Sedana Medical AB (publ)
STO:SEDANA
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
10.68
28.05
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SEDANA stock under the Base Case scenario is 7.55 SEK. Compared to the current market price of 11.96 SEK, Sedana Medical AB (publ) is Overvalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Sedana Medical AB (publ)
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SEDANA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Sedana Medical AB (publ)
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Sedana Medical AB (publ)
Balance Sheet Decomposition
Sedana Medical AB (publ)
Current Assets | 308.8m |
Cash & Short-Term Investments | 226.4m |
Receivables | 26.2m |
Other Current Assets | 56.2m |
Non-Current Assets | 689.4m |
PP&E | 10.6m |
Intangibles | 678.8m |
Other Non-Current Assets | 69k |
Current Liabilities | 44.7m |
Accounts Payable | 4m |
Accrued Liabilities | 26.7m |
Other Current Liabilities | 14m |
Non-Current Liabilities | 3.5m |
Long-Term Debt | 3.5m |
Other Non-Current Liabilities | 29k |
Earnings Waterfall
Sedana Medical AB (publ)
Revenue
|
174.1m
SEK
|
Cost of Revenue
|
-51.2m
SEK
|
Gross Profit
|
122.9m
SEK
|
Operating Expenses
|
-176.2m
SEK
|
Operating Income
|
-53.3m
SEK
|
Other Expenses
|
-4m
SEK
|
Net Income
|
-57.2m
SEK
|
Free Cash Flow Analysis
Sedana Medical AB (publ)
SEK | |
Free Cash Flow | SEK |
Sedana Medical's first half of 2024 shows significant milestones and robust sales growth. The company achieved record sales in both Q1 and Q2, growing 20% compared to last year. Despite a weaker performance in Germany, direct markets like Spain and the U.K. demonstrated strong growth. The company completed enrollment for U.S. clinical trials, paving the way for U.S. market entry. They also acquired their main supplier, expected to enhance EBITDA by 2 percentage points. Overall, Sedana is on track to meet or exceed its annual growth guidance of 14-18%.
What is Earnings Call?
SEDANA Profitability Score
Profitability Due Diligence
Sedana Medical AB (publ)'s profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Score
Sedana Medical AB (publ)'s profitability score is 34/100. The higher the profitability score, the more profitable the company is.
SEDANA Solvency Score
Solvency Due Diligence
Sedana Medical AB (publ)'s solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Sedana Medical AB (publ)'s solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SEDANA Price Targets Summary
Sedana Medical AB (publ)
According to Wall Street analysts, the average 1-year price target for SEDANA is 24.48 SEK with a low forecast of 24.24 SEK and a high forecast of 25.2 SEK.
Dividends
Current shareholder yield for SEDANA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
SEDANA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
Contact
IPO
Employees
Officers
The intrinsic value of one SEDANA stock under the Base Case scenario is 7.55 SEK.
Compared to the current market price of 11.96 SEK, Sedana Medical AB (publ) is Overvalued by 37%.